June 9, 2020 / 8:25 PM / 24 days ago

BRIEF-Teva Pharmaceutical Shareholders Approve Amendment To Terms Of Office And Employment Of CEO

June 9 (Reuters) - Teva Pharmaceutical Industries Ltd :

* TEVA PHARMACEUTICAL INDUSTRIES - SHAREHOLDERS APPROVED AMENDMENT NO. 1 TO TERMS OF OFFICE AND EMPLOYMENT OF CO’S CEO KÅRE SCHULTZ AT ANNUAL MEETING

* TEVA PHARMACEUTICAL - INITIAL TERM OF SCHULTZ'S EMPLOYMENT WILL EXTEND BY ONE YEAR TO A SIXTH YEAR, FROM NOV 1, 2022 TO NOV 1, 2023 Source : (bit.ly/3cJ4xjD) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below